Toggle navigation
About
Company Overview
Partners and Distributors
Our People
Scientific Advisory Board
Corporate Directory
Corporate Governance
COVID-19: Information for People Using Bronchitol
Approved Products
Manufacturing Facilities
Bronchitol®
Cystic Fibrosis
Clinical Trials
Publications
Patents
Partners and Distributors
COVID-19: Information for People Using Bronchitol
Aridol®
Asthma
Clinical Trials
Publications
Patents
Distributors
Product Pipeline
Drug Discovery
Facilities & Capabilities
Publications & Posters
Patents
Amine Oxidase Platform
SSAO Inhibitor BI 1467335
LOXL2 Inhibitors
LOX Systemic Inhibitor
Other Amine Oxidase Inhibitor Programs
Other Pipeline Assets
Orbital® Dry Powder Inhaler
News
Patients & Prescribers
Contact
Media
Follow us
Investor Centre
Investor Centre
News
ASX Announcements
Quarterly Updates
Annual and Half Year Reports
Investor Presentations
Shareholder Services
Upcoming Events
Analyst Coverage
Major Shareholders
Corporate Governance
Subscribe to our Emails
Videos and Podcasts
Investor Centre
Quarterly Updates
Quarterly Updates
Quarterly Updates
Skip to
February
April
July
October
2008
6th
Feb 08
Quarterly Report to Shareholders No 17 - December 2007
Read quarterly update - pdf
‹
Prev
1
2
Archives
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
COVID-19: Information for People Using Bronchitol
Read more
Dismiss
